Nansen Neuroscience Network "Fully Support" NOR-OPENSCREEN
FOR IMMEDIATE RELEASE
The Nansen Neuroscience Network (NNN) fully support the establishment of NOR-OPENSCREEN. Leif Rune Skymoen (CEO) has stated that "further strengthening Norwegian Competency and infrastructure" would give "innovative biomedicine companies an advantage in develop(ing) neuroscience pharmaceuticals of the future" as well as "shorten the time to market for innovative products." Neuroscience is considered one of the strongest areas of Norwegian research, which was highlighted by the recent Nobel Prize award to May-Britt Moser and Edvard I. Moser. The support of NNN to NOR-OPENSCREEN shows how this project can strengthen our existing capabilities within the country.
Notes to Editors:
NOR-Openscreen is the Norwegian node of the EU-Openscreen infrastructure project. They support the discovery of biologically active substances in all areas of the Life Sciences by providing transnational, open access to the most advanced technologies, chemical and biological resources as well as expertise through Europe.
Nansen Neuroscience Network
Nansen Neuroscience Network (NNN) is a non-profit member organization working to facilitate innovation in neuroscience. We have more than 40 members, including research groups and institutions, university technology transfer offices, startup-companies, and established industry. We serve as a link between academia and industry, and we cover the whole value chain in neuroscience research and development. Our industry member list comprise both Nordic companies and most of the global pharma industry players with a neuroscience product portfolio or CNS research programs. Neuroscience is considered one of the strongest areas of Norwegian medical research.